Xianle Health Technology Co., Ltd.
2025 Annual Equity Distribution Implementation Announcement
The company and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- The 2025 annual equity distribution plan of Xianle Health Technology Co., Ltd. (hereinafter referred to as "the Company") was approved at the 2026 Annual General Meeting of Shareholders held on May 20, 2026.
- Shares held in the company's repurchase special securities account do not enjoy the rights to profit distribution and capital reserve fund conversion into share capital. Therefore, the 1,285,600 shares in the repurchase special securities account will not participate in this equity distribution. The equity distribution plan is based on the total share capital of 308,691,663 shares, minus the repurchased shares of 1,285,600 shares, resulting in a base of 307,406,063 shares. A cash dividend of 1.30 RMB (including tax) will be distributed for every 10 shares to all shareholders, totaling 39,962,788.19 RMB (including tax). There will be no capital reserve fund conversion into share capital, and no bonus shares will be issued; the remaining undistributed profits will be carried forward to the next year.
- After the implementation of this equity distribution, the cash dividend per 10 shares (including tax) will be calculated as follows: Total actual cash dividend ÷ Total share capital (including shares held in the repurchase special securities account) = 39,962,788.19 RMB ÷ 308,691,663 shares × 10 shares ≈ 1.294585 RMB/share (retaining six decimal places, with the last digit truncated). The reference price for ex-dividend trading after this equity distribution will be calculated as: (Closing price on the record date - per share cash dividend based on total share capital) ÷ (1 + per share conversion into additional shares based on total share capital) = (Closing price on the record date - 0.1294585 RMB) ÷ (1).